The FDA is pressing ahead with national licensure standards for wholesale distributors and third-party logistics providers, raising urgent questions across the pharmaceutical supply chain. At the heart of the debate is whether
More
On 26 August 2026, President Trump signed Executive Order 14420, declaring a national emergency to secure the United States bulk-power system from foreign threats. The order invokes the International Emergency Economic Powers
More
California’s legislature has passed an amended version of Senate Bill 690, a move that significantly reshapes how website privacy claims can be pursued under state law. For the past two years, plaintiffs’
More
Justice Samuel Alito has released his long-delayed annual financial disclosure, confirming he retains significant investments in oil and gas companies. The disclosure was originally due on May 15 but was not posted
More
Law firm office leasing jumped 17% year-over-year in the first half of 2026, reaching nearly 12.2 million square feet, according to new data from Cushman & Wakefield. The figures, reported by Reuters,
More
BP shares have delivered a strong run for investors, rising around 20% over the past year and 70% over five years, with dividends pushing total returns close to 100%. The FTSE 100
More
The iShares Expanded Tech-Software Sector ETF (NYSE: IGV) has returned to the spotlight as software stocks regain momentum across global markets in 2026. Investor appetite for software names has grown considerably following
More
EasyJet (EZJ) is set to return to the FTSE 100 index following a period outside the UK’s premier stock market benchmark. The airline’s return marks a significant moment for the budget carrier,
More
Andy Burnham has been enjoying a presidential summer, communicating with the public through podcasts and social media while delivering the occasional speech and touring the country. The new Prime Minister has largely
More
The White House has announced a second wave of most favoured nation drug pricing agreements, this time targeting nine medium-sized pharmaceutical companies across multiple continents. The latest round includes Alcon, Astellas Pharma,
More